2NORGREN I, HIATT W R, DORMANDY J A, et al. Inter-Society Consensus for the Management of Peripher- al Arterial Disease (TASC II ) [J]. Eur J Vase Endo- vase Surg, 2007, 33 (Suppl 1 ) : S5-S67.
3LVERSEN M M, TELL G S, RIISE T, et al. History of foot ulcer increases mortality among individuals with dia- betes ten-year follow-up of the nord-tr? ndelag health study, norway [J]. Diabetes Care, 2009 32 (12): 2193-2199.
4ARTINIAN NT, FLETCHER G F, MOZAFFARIAN D, et al. Interventions to promote physical activity and diet- ary lifestyle changes for cardiovascular risk factor reduc- tion in adults [J]. Circulation, 2010 , 122 (4) : 406- 441.
5DONATH M Y, SCHUMANN D M, FAULENBACH M, et al. Islet inflammation in type 2 diabetes from metabol- ic stress to therapy [J]. Diabetes Care, 2008, 31 (Suppl 1 ) : S161-S164.
6ANAN F, TAKAHASHI N, SHINOHARA T, et al Smoking is associated with insulin resistance and cardi- ovascular autonomic dysfunction in type 2 diabetic pa- tients [ J]. Eur J Clin Invest, 2006, 36 (7) : 459- 465.
7WANG L, HU S Y, WU X, JU X F. Significances of NT-proBNP and hs-CRP in heart failure [J]. Zhonghua Yi Xue Za Zhi, 2010, 90 (23) : 1635-1636.
8VAN BUSSEL B C, SCHOUTEN F, HENRY R M, et al. Endothelial dysfunction and low-grade inflammation are associated with greater arterial stiffness over a 6-year period[J]. Hypertension, 2011, 58 (4): 588-595.
9COPPOLA G, CORRADO E, MURATORI I, et al. In- creased hs-CRP levels and fibrinogen influence vascular event risk in diabetes mellitus [ J ]. Int J Cardiol, 2006, 106 (1) : 16-20.
10VIRMANI R, BURKE A P, FARB A, et al. Pathology of the vulnerable plaque [ J ]. J Am Coll Cardiol, 2006, 47 ( 8 Suppl) : C13-18.
